Studies on the melanin affinity of haloperidol

Area of Science:

• Neuroscience
• Pharmacology
• Toxicology

Background:

• Haloperidol is a widely used antipsychotic medication.
• Tardive dyskinesia is a serious side effect associated with long-term haloperidol use.
• Melanin is a pigment found in various tissues, including the substantia nigra.

Purpose of the Study:

• To investigate the distribution and retention of 3H-haloperidol in melanin-containing tissues.
• To explore the in vitro binding of haloperidol to melanin.
• To assess the potential role of melanin affinity in haloperidol-induced neurotoxicity.

Main Methods:

• Whole-body autoradiography in mice to track 3H-haloperidol distribution.
• Impulse counting of excised tissue samples.
• In vitro binding assays using beef-eye melanin and dopamine melanin.

Main Results:

• Extensive accumulation and retention of 3H-haloperidol in melanin-rich tissues, especially pigmented eyes.
• High concentration in pigmented eyes 24 hours post-injection, with significant residual radioactivity at 90 days.
• Haloperidol demonstrated strong binding to both beef-eye and dopamine melanin in vitro, with higher affinity than chlorpromazine and chloroquine.

Conclusions:

• Haloperidol exhibits significant melanin affinity, leading to accumulation in pigmented tissues.
• This affinity suggests potential accumulation in the substantia nigra's pigmented neurons during long-term therapy.
• Melanin binding may be a key factor in the development of haloperidol-induced tardive dyskinesia.